» Journals » Biomol Biomed

Biomolecules & Biomedicine

Biomolecules & Biomedicine is a scientific journal, published since 2023 in English. The journal's country of origin is Bosnia and Herzegovina and its primary focus areas are general medicine and biochemistry.

Details
Abbr. Biomol Biomed
Start 2023
End Continuing
Frequency Six issues a year
p-ISSN 2831-0896
e-ISSN 2831-090X
Language English
Recent Articles
11.
Zottel A, Samec N, Jovcevska I
Biomol Biomed . 2025 Feb; PMID: 39977830
Glioblastoma (GBM) is one of the deadliest cancers, and the survival rate has remained low for decades. The aim of the study was the construction of the programmed death-ligand 1...
12.
Vucinic D, Lekic M, Zauhar G, Zamolo G
Biomol Biomed . 2025 Feb; PMID: 39976551
Melanoma progression is influenced by complex interactions between tumor cells and the immune microenvironment. This study examined the relationship between microphthalmia-associated transcription factor (MITF) expression and the immune microenvironment in...
13.
Dong Q, Xu H, Xu P, Liu J
Biomol Biomed . 2025 Feb; PMID: 39976478
Paraquat (PQ) is a highly effective herbicide widely used in agricultural production, known for its strong herbicidal power, rapid action, and minimal environmental pollution. However, it is also highly toxic...
14.
Jin Y, Fu C, Guo M, Yang Q
Biomol Biomed . 2025 Feb; PMID: 39976471
Cerebral ischemia-reperfusion injury (CIRI) is the primary cause of damage following ischemic stroke, with ferroptosis serving as a key pathophysiological factor in CIRI. Pterostilbene (PTE) has been shown to reduce...
15.
Ding F, Wang H, Qiao G, Zhang Z
Biomol Biomed . 2025 Feb; PMID: 39957615
Methylene blue (MB) has antioxidant properties, yet its role in acute lung injury (ALI) induced by hypothermic circulatory arrest (HCA) remains unexplored. This study investigates MB's effects and underlying regulatory...
16.
Zou W, Lou J, Yi Y, Cui Y, Chu X
Biomol Biomed . 2025 Feb; PMID: 39937205
Cervical cancer poses significant clinical challenges, particularly in advanced stages. This study explores the therapeutic potential of andrographolide (AND), a bioactive compound derived from Andrographis paniculata, in mitigating cervical cancer...
17.
Shi Y, Pan Z, Duan J, Wang Z, Fang Y, Tang B, et al.
Biomol Biomed . 2025 Feb; PMID: 39937175
ST6 β-galactoside α2,6-sialyltransferase 1 (ST6GAL1), a crucial enzyme for tumor-associated sialic acid modification, has been reported to positively correlate with colorectal cancer (CRC) tumorigenesis; however, the underlying mechanism remains unclear....
18.
Chen Z, Lu J, Chang T, Zhang D, Zhang Y, Liu M, et al.
Biomol Biomed . 2025 Feb; PMID: 39937170
Jianpi Yiqi Busui Prescription (JYBP), a traditional Chinese medicine formula (TCM), is used in the treatment of myasthenia gravis (MG). However, its mechanisms of action still require further clarification. In...
19.
Li H, Wang P, Chen H, Shao Y, Luo H
Biomol Biomed . 2025 Feb; PMID: 39910812
Esophageal cancer (EC) is a highly aggressive malignancy with limited treatment options. Nei like DNA glycosylase 3 (NEIL3) and DNA topoisomerase II alpha (TOP2A) have been identified as potential therapeutic...
20.
Yetisgin E, Gokce A, Dogan K
Biomol Biomed . 2025 Feb; PMID: 39907598
SRY-box transcription factor 9 (SOX9) has been reported to be overexpressed in a wide variety of gastrointestinal malignancies. While its role has been studied in gastric cancer (GC), the results...